Why the study?
Do methylxanthines facilitate noradrenaline release and elicit cardiac arrhythmias in patients with ischemic heart disease?
Do methylxanthines facilitate noradrenaline release and elicit cardiac arrhythmias in patients with ischemic heart disease?
This paper proposes a mechanistic hypothesis that methylxanthines like caffeine may trigger arrhythmias in ischemic heart disease by amplifying noradrenaline release during hypoxia.
Authors
No takes yet. Share an insight, caveat, or question.
Hypothesis-generating for methylxanthine-triggered arrhythmias in IHD; leaves open clinical relevance and does not support practice changes.
Wennmalm et al. (1989) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: